Award

VEO 000693

Funder: GlaxoSmithKline Biologicals

Funded outputs count: 1

Funder award ID: VEO 000693

OpenAlex ID: G3510417197

The outpatient economic burden of respiratory syncytial virus infection in adults aged ≥ 60 years in Germany: results from the BUCOSS study

2026 · Roland Diel, Paul Schmidt, et al. · Respiratory Research